Enzo Biochem Inc (ENZ)
0.97
0.00 (0.00%)
USD |
NYSE |
Nov 22, 16:00
0.9553
-0.01
(-1.52%)
After-Hours: 20:00
Enzo Biochem Net Income (Quarterly): -13.38M for July 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -13.38M |
| April 30, 2024 | -3.02M |
| January 31, 2024 | -3.061M |
| October 31, 2023 | -6.616M |
| July 31, 2023 | 57.43M |
| April 30, 2023 | -15.19M |
| January 31, 2023 | -11.32M |
| October 31, 2022 | -10.64M |
| July 31, 2022 | -8.433M |
| April 30, 2022 | -4.854M |
| January 31, 2022 | -2.655M |
| October 31, 2021 | -2.319M |
| July 31, 2021 | 3.268M |
| April 30, 2021 | 2.006M |
| January 31, 2021 | 2.302M |
| October 31, 2020 | 0.299M |
| July 31, 2020 | -3.325M |
| April 30, 2020 | -9.86M |
| January 31, 2020 | -7.687M |
| October 31, 2019 | -7.648M |
| July 31, 2019 | -5.387M |
| April 30, 2019 | 22.26M |
| January 31, 2019 | -8.408M |
| October 31, 2018 | -5.981M |
| July 31, 2018 | -5.764M |
| Date | Value |
|---|---|
| April 30, 2018 | -3.016M |
| January 31, 2018 | -0.901M |
| October 31, 2017 | -0.64M |
| July 31, 2017 | 0.094M |
| April 30, 2017 | -0.071M |
| January 31, 2017 | -1.053M |
| October 31, 2016 | -1.474M |
| July 31, 2016 | 36.14M |
| April 30, 2016 | -2.115M |
| January 31, 2016 | 6.832M |
| October 31, 2015 | 4.434M |
| July 31, 2015 | 8.442M |
| April 30, 2015 | -2.907M |
| January 31, 2015 | -4.091M |
| October 31, 2014 | -3.729M |
| July 31, 2014 | -3.169M |
| April 30, 2014 | -0.455M |
| January 31, 2014 | -3.566M |
| October 31, 2013 | -2.787M |
| July 31, 2013 | -3.102M |
| April 30, 2013 | -5.77M |
| January 31, 2013 | -5.674M |
| October 31, 2012 | -3.691M |
| July 31, 2012 | -27.14M |
| April 30, 2012 | -3.411M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-15.19M
Minimum
Apr 2023
57.43M
Maximum
Jul 2023
-1.950M
Average
-3.325M
Median
Jul 2020
Net Income (Quarterly) Benchmarks
| Delcath Systems Inc | 1.864M |
| Star Equity Holdings Inc | -1.97M |
| Exact Sciences Corp | -38.24M |
| CytoSorbents Corp | -2.334M |
| Progyny Inc | 10.42M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.526M |
| Total Expenses (Quarterly) | 12.72M |
| EPS Diluted (Quarterly) | -0.26 |
| Enterprise Value | -1.429M |
| Gross Profit Margin (Quarterly) | 42.78% |
| Profit Margin (Quarterly) | -177.8% |
| Earnings Yield | -52.58% |
| Normalized Earnings Yield | -16.83 |